公开(公告)号：US20230218709A1

公开(公告)日：2023-07-13

申请号：US17885368

申请日：2022-08-10

Applicant: Acerus Pharmaceuticals USA, LLC

Inventor： Seymour Fein

IPC: A61K38/095 ,  A61K9/00 ,  A61M15/08 ,  A61M11/00 ,  A61M11/06

CPC classification number: A61K38/095 ,  A61K9/0043 ,  A61M15/08 ,  A61M11/008 ,  A61M11/06

Abstract: Disclosed is a family of intranasal spray dispensers for administering uniform low doses of desmopressin so as to achieve safe antidiuresis in human patients. The dispensers of the invention may be used in the treatment of nocturia, primary nocturnal enuresis, incontinence, urinary frequency, diabetes insipidus, or any disease or syndrome where desmopressin therapy is useful or where safe temporary suppression of urine production may lead to beneficial health effects or increased convenience in voiding control.

公开(公告)号：US12090190B2

公开(公告)日：2024-09-17

申请号：US17885368

申请日：2022-08-10

Applicant: Acerus Pharmaceuticals USA, LLC

Inventor： Seymour Fein

IPC: A61K38/095 ,  A61K9/00 ,  A61M15/08 ,  A61M11/00 ,  A61M11/06

CPC classification number: A61K38/095 ,  A61K9/0043 ,  A61M15/08 ,  A61M11/008 ,  A61M11/06

Abstract: Disclosed is a family of intranasal spray dispensers for administering uniform low doses of desmopressin so as to achieve safe antidiuresis in human patients. The dispensers of the invention may be used in the treatment of nocturia, primary nocturnal enuresis, incontinence, urinary frequency, diabetes insipidus, or any disease or syndrome where desmopressin therapy is useful or where safe temporary suppression of urine production may lead to beneficial health effects or increased convenience in voiding control.

公开(公告)号：US20240342407A1

公开(公告)日：2024-10-17

申请号：US18506719

申请日：2023-11-10

Applicant: Acerus Pharmaceuticals USA, LLC

Inventor： Seymour Fein

IPC: A61M15/08 ,  A61K9/00 ,  A61K31/4025 ,  A61K38/095 ,  A61K47/08 ,  A61K47/26 ,  A61K47/44

CPC classification number: A61M15/08 ,  A61K9/0043 ,  A61K31/4025 ,  A61K38/095 ,  A61K47/08 ,  A61K47/26 ,  A61K47/44 ,  A61M2205/276

Abstract: Disclosed is a family of intranasal spray dispensers for administering uniform low doses of desmopressin so as to achieve safe antidiuresis in human patients. The dispensers of the invention may be used in the treatment of nocturia, primary nocturnal enuresis, incontinence, urinary frequency, diabetes insipidus, or any disease or syndrome where desmopressin therapy is useful or where safe temporary suppression of urine production may lead to beneficial health effects or increased convenience in voiding control.